Provided by Tiger Trade Technology Pte. Ltd.

BioAge Labs Inc.

7.75
-0.4300-5.26%
Post-market: 7.750.00000.00%19:42 EDT
Volume:715.82K
Turnover:5.60M
Market Cap:355.70M
PE:-3.27
High:8.28
Open:8.21
Low:7.62
Close:8.18
52wk High:25.96
52wk Low:4.68
Shares:45.90M
Float Shares:37.58M
Volume Ratio:1.25
T/O Rate:1.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3710
EPS(LYR):-2.2432
ROE:-28.21%
ROA:-18.47%
PB:0.95
PE(LYR):-3.45

Loading ...

Jan 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 04, 2025

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 09, 2025

Major Issues Report

Form 8-K - Current report
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
May 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
Mar 20, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]